Letermovir Approved for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression.
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression.
Severe renal dysfunction and short-term dialysis are common before heart-alone transplantation, a study found.
Current screening guidelines may not capture all cases of hyperaldosteronism among patients with ESKD.
Hospitalization of living kidney donors may be “a sentinel event” for adverse outcomes.
Removing the race coefficient from the KDPI may increase use of Black deceased donor kidneys, according to investigators.
Venous thromboembolism occurred in the graft in 15.4% of patients.
Vitamin K deficiency is common among kidney transplant recipients.
“Pressures, such as outcomes reporting and perceived inadequate risk adjustment, disincentivize transplant programs from using high KDPI kidneys,” investigator says.
Providers’ response to patient non-adherence was partly informed by their experiences working with patients, the training they received, and their own implicit biases, according to investigators.
Patients aged 65 years or older had significant 84% lower odds of being waitlisted for a first transplant compared with patients aged 18 to 64 years.